Latest Breaking News On - ரோட்ரிகோ விகா - Page 6 : comparemela.com

2 Min Read RIO DE JANEIRO, March 5 (Reuters) - Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday. The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have originated in the Amazonian city of Manaus, said the source, who requested anonymity as the results have not yet been made public. The source did not provide the exact efficacy of the vaccine against the variant. They said the full results of the study should be released soon, possibly in March.

Estado do rioSouth africaSouth africanRodrigo viga gaierHugh lawsonThomson reuters trust principlesUniversity of oxfordRodrigo vigaGram slatteryThomson reuters trustCoronavirus brazilVariant exclusiveChildren youth issuesCompany newsCorona virusEmerging market countries